Enzymatica

2,54 SEK

+2,01%

Mindre end 1K følgere

ENZY

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Værdiansættelse

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Enzymatica

EV/S

Medianen 2019-2021

P/B

Medianen 2019-2025

 
2019202020212022202320242025
Aktiekurs (SEK)3,6717,298,084,163,651,581,90
Aktier154,5154,5157,6177,6177,6242,7242,7
Markedsværdi567,02.670,81.273,6739,2648,0383,5461,2
Enterprise value540,22.659,51.244,6----
EV/S8,823,921,7----
EV/EBITDAneg.neg.neg.----
EV/EBITneg.neg.neg.----
P/Eneg.neg.neg.neg.neg.neg.neg.
P/B4,7625,0410,195,858,462,173,71
P/S9,224,022,215,112,78,48,6
Udbytteprocent0,0 %0,0 %0,0 %0,0 %0,0 %0,0 %0,0 %
Equity ratio80,7 %65,8 %79,6 %72,4 %60,8 %90,3 %87,5 %
Gearing ratio2,1 %12,0 %1,2 %17,7 %34,1 %1,2 %0,8 %